Related by context. Frequent words. (Click for all words.) 67 DG# [001] 63 LX# [003] 62 ISIS # 59 preclinical studies 58 ADL# 58 preclinical 58 NGX# 58 orally administered 57 PF # [001] 57 selective inhibitor 57 RDEA# 57 HspE7 57 SPP# [001] 57 antisense drug 56 XL# [003] 56 HE# [002] 56 MBX 56 ADX# 56 Phase 2a trial 56 potent inhibitor 56 MLN# 56 Phase 1b 56 AP# [003] 56 Phase 2a clinical 56 Locteron 55 pharmacokinetic profile 55 Zerenex 55 IDX# 55 INGN 55 perifosine 55 investigational compound 55 ALTU 55 CK # 54 PRX # 54 Phase Ib 54 Marqibo 54 CYT# 54 Phase IIa clinical 54 AZD# 54 Phase 2b 54 Perifosine 54 APD# 54 multiple ascending dose 54 CUDC 54 Azixa 54 humanized monoclonal antibody 53 JANUVIA 53 antiviral activity 53 CRx 53 IND enabling 53 Preclinical studies 53 HGS ETR1 53 Phase 2b trial 53 Phase IIa trial 53 kinase inhibitor 53 MGCD# [002] 53 Phase 2b clinical 53 Phase 2b study 53 LymphoStat B 53 MGCD# [001] 53 Phase IIa 53 INCB# [002] 52 sitagliptin 52 PBT2 52 AT# [002] 52 pharmacodynamic 52 MDV# 52 anti angiogenic 52 prodrug 52 bevirimat 52 AEZS 52 Metabasis 52 AMR# 52 Phase 2a 52 TLR7 52 investigational drug 52 carfilzomib 51 tivozanib 51 aliskiren 51 vitro studies 51 HDAC inhibitors 51 PLX# 51 oral bioavailability 51 receptor agonist 51 IMGN# 51 TMC# [001] 51 eculizumab 51 APF# 51 mipomersen 51 GATTEX 51 pharmacokinetic 51 ZYBRESTAT 51 vilazodone 51 preclinical models 51 MultiStem 51 ARRY 50 RG# [001] 50 CORLUX 50 phase IIb 50 tolerability profile 50 alfimeprase